Public consultation is part of the EUCAST decision process. The consultation period is 4 - 12 weeks, and the dates of the beginning and end of the period is clearly stated.
The (preliminary) breakpoint table for 2025 (v.15.0) is available for consultation (5 - 16 December 2024). Breakpoint table v 15.0 (for screen). The consultation is primarily to:
Reference method for M. tuberculosis susceptibility testing for drugs that require DMSO. Consultation from the subcommittee on Antimycobacterial susceptibility testing closed 19 April, 2024. Comments and EUCAST responses (7 October 2024).
EUCAST public consultation on proposed changes to the 2024 (v. 14.0) breapoint table (30 September - 1 November 2023). Comments and EUCAST response (13 November 2023).
Looking for more information? Get in touch with an EUCAST representative today!
We’ve prepared a short video to help you get familiar with the new layout and features.